OPKO Health, Inc. (OPK)
Pre-market:
| Previous close | 1.3700 |
| Open | 1.3800 |
| Bid | 1.4100 x 2800 |
| Ask | 1.4400 x 1400 |
| Day's range | 1.3800 - 1.4300 |
| 52-week range | 0.8500 - 2.2400 |
| Volume | |
| Avg. volume | 7,432,369 |
| Market cap | 989.729M |
| Beta (5Y monthly) | 1.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3500 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.25 |
Simply Wall St.Bullish OPKO Health Insiders Loaded Up On US$12.9m Of Stock
Quite a few insiders have dramatically grown their holdings in OPKO Health, Inc. ( NASDAQ:OPK ) over the past 12...
GlobeNewswireOPKO Health to Participate in the Jefferies Global Healthcare Conference
MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time. The fireside chat will be webcast live and available for replay in the Investors section of OPKO
ZacksOPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
